Immunization with a novel dc-targeting lentiviral vector induces polyfunctional cd8 t cell responses and therapeutic anti-tumor immunity

被引：0
|
作者：
Robbins, S. H. [1 ,2 ]
Clarke, B. Kelley [1 ]
Odegard, J. M. [1 ]
Tareen, S. U. [1 ]
Van Hoeven, N. [1 ]
Campbell, D. J. [1 ]
Nicholai, C. J. [1 ]
Slough, M. M. [1 ]
Vin, C. [1 ]
Baltimore, D. [2 ]
Reed, S. G. [1 ]
Dubensky, T. W., Jr. [1 ]
机构：
[1] Immune Design Corp, Seattle, WA USA
[2] CALTECH, Pasadena, CA 91125 USA
来源：
CYTOKINE | 2011年 / 56卷 / 01期
关键词：
D O I：
10.1016/j.cyto.2011.07.246
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] THERAPEUTIC MODULATION OF THE PHAGOCYTIC AXIS SPARKS ANTI-TUMOR CD8 T CELL RESPONSES IN GLIOBLASTOMA
    von Roemeling, Christina
    Qie, Yaqing
    Jiang, Wen
    Chen, Yuanxin
    Shih, Kevin
    Liu, Xiujie
    Knight, Joshua
    Tian, Rong
    Chan, Charles
    Kim, Betty
    NEURO-ONCOLOGY, 2018, 20 : 124 - 124
  • [2] The role of radiotherapy in driving anti-tumor CD8 T cell responses
    Zebertavage, Lauren
    Alice, Alejandro
    Crittenden, Marka
    Gough, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+T cell anti-tumor immunity
    Zheng, Yanyan
    Lu, Zheng
    Zhu, Fei
    Zhao, Guangya
    Shao, Yingxiang
    Lu, Bowen
    Ding, Jiage
    Wang, Gang
    Fang, Lin
    Zheng, Junnian
    Chai, Dafei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [4] Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene
    Rowe, HM
    Lopes, L
    Ikeda, Y
    Bailey, R
    Barde, I
    Zenke, M
    Chain, BM
    Collins, MK
    MOLECULAR THERAPY, 2006, 13 (02) : 310 - 319
  • [5] Mitochondrial metabolic flexibility is critical for CD8 T cell anti-tumor immunity
    Chen, Chao
    Qu, Cheng-Kui
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [6] B CELL PRIMED CD8 T CELLS GENERATE SIMILAR PHENOTYPE, FUNCTION AND ANTI-TUMOR RESPONSES TO DC PRIMED CD8 T CELLS
    Rastogi, Ichwaku
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A286 - A286
  • [7] PGC-1α engineered CD8 T cell for enhanced anti-tumor immunity
    Dumauthioz, Nina
    Tschumi, Benjamin
    Wenes, Mathias
    Wang, Haiping
    Franco, Fabien
    Lopez-Mejia, Isabel
    Fajas, Lluis
    Ho, Ping-Chih
    Donda, Alena
    Romero, Pedro
    Zhang, Lianjun
    SWISS MEDICAL WEEKLY, 2019, : 23S - 24S
  • [8] Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma
    Zheng, Yanyan
    Lu, Zheng
    Ding, Jiage
    Jiang, Nan
    Wang, Jiawei
    Yang, Jie
    Song, Jingyuan
    Chen, Hongliang
    Fang, Lin
    Li, Huizhong
    Tian, Hui
    Wang, Gang
    Zheng, Junnian
    Chai, Dafei
    CANCERS, 2022, 14 (18)
  • [9] DEFINING THE POST-SEPTIC LESIONS IN ANTI-TUMOR CD8 T CELL RESPONSES
    Danahy, Derek B.
    Jensen, Isaac J.
    Griffith, Thomas S.
    Badovinac, Vladimir P.
    SHOCK, 2018, 49 (06): : 95 - 95
  • [10] Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity
    Jacqueline A. Turner
    Malia A. Fredrickson
    Marc D’Antonio
    Elizabeth Katsnelson
    Morgan MacBeth
    Robert Van Gulick
    Tugs-Saikhan Chimed
    Martin McCarter
    Angelo D’Alessandro
    William A. Robinson
    Kasey L. Couts
    Roberta Pelanda
    Jared Klarquist
    Richard P. Tobin
    Raul M. Torres
    Nature Communications, 14
12345